Literature DB >> 18654595

Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas).

Emad A Rakha, Ian O Ellis, Jorge S Reis-Filho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18654595     DOI： 10.1038/modpathol.2008.67

Source DB:  PubMed          Journal:  Mod Pathol        ISSN： 0893-3952            Impact factor:   7.842


× No keyword cloud information.
  5 in total

1.  Triple-Negative Breast Cancer: Clinical and Histological Correlations.

Authors:  Zeinab Elsawaf; Hans-Peter Sinn
Journal:  Breast Care (Basel)       Date:  2011-08-26       Impact factor: 2.860

Review 2.  Subtyping of triple-negative breast cancer: implications for therapy.

Authors:  Vandana G Abramson; Brian D Lehmann; Tarah J Ballinger; Jennifer A Pietenpol
Journal:  Cancer       Date:  2014-07-16       Impact factor: 6.860

3.  Molecular Heterogeneity of Triple Negative Breast Cancer.

Authors:  Vandana G Abramson; Ingrid A Mayer
Journal:  Curr Breast Cancer Rep       Date:  2014-09-01

4.  A phenotypic mouse model of basaloid breast tumors.

Authors:  Soyoung Kim; Avtar Roopra; Caroline M Alexander
Journal:  PLoS One       Date:  2012-02-09       Impact factor: 3.240

5.  Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines.

Authors:  Al-Madhagi Radia; Al-Madhagi Yaser; Xiaoqian Ma; Juan Zhang; Cejun Yang; Qiong Dong; Pengfei Rong; Bin Ye; Sheng Liu; Wei Wang
Journal:  Int J Mol Sci       Date:  2013-04-11       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.